JHOME

JHOME is a technology company that focuses on biological immune in vitro diagnosis, home medical electronics, and medical imaging.

Number of Funding Rounds

Total Funding Amount

3

¥279.83M

JHOME has raised a total of ¥279.83M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2015 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 7, 2015	Post-IPO Equity	¥168.20M	6	—	—	Detail
Mar 20, 2015	Post-IPO Equity	¥82.33M	6	—	—	Detail
May 6, 2014	Post-IPO Equity	¥29.30M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

12

JHOME is funded by 12 investors. Changjiang Fund and Yi Yuan Fund are the most recent investors.

Investor Name	Lead Investor	Funding Round
Changjiang Fund	—	Post-IPO Equity
Yi Yuan Fund	—	Post-IPO Equity
Shenzhen Hillview Capital Management	—	Post-IPO Equity
Baotou Yunheng	—	Post-IPO Equity
Chinanx Financial Services	—	Post-IPO Equity
Youhe Fengchao	—	Post-IPO Equity
Wuhan Bangyida Investment Consulting	—	Post-IPO Equity
Beijing Chengye Investment Fund Management	—	Post-IPO Equity
Baoying Zichan	—	Post-IPO Equity
Hao Xi Capital	—	Post-IPO Equity